Overview: Fludarabine Phosphate 50 mg Injection (Lyophilized Powder) is a prescription chemotherapy medicine containing Fludarabine Phosphate (50 mg) used in the treatment of hematologic malignancies including chronic lymphocytic leukemia (CLL) by interfering with DNA synthesis in rapidly dividing cancer cells. Key Benefits: – Effective in treating CLL and select hematologic cancers – Inhibits DNA synthesis in cancer cells to reduce tumor progression – Administered by qualified healthcare professionals in clinical settings Composition: Fludarabine Phosphate (50 mg) How It Works: Fludarabine Phosphate is a purine analog that incorporates into DNA and RNA and inhibits DNA polymerase and ribonucleotide reductase, leading to disruption of DNA synthesis and induction of cancer cell death. Usage Instructions: – Administer only under supervision of a qualified healthcare provider – Dosage and schedule determined by disease type and patient condition – Not for self-administration Side Effects: – Low blood cell counts (anemia, neutropenia, thrombocytopenia) – Nausea, vomiting, diarrhea – Fatigue, fever, increased infection risk Precautions: – Regular monitoring of complete blood counts and organ function is required – Use effective contraception during treatment and consult doctor if pregnant or breastfeeding Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.